PyK2 activation is associated with the initiation of olfactory receptor signaling in prostate cancer cells [59], pre-malignant signaling in pancreatic ductal adenocarcinoma [60], and pituitary adenylate cyclase-induced phosphorylation-activating polypeptide receptors in non-small lung cancer cells [61]. This evidence concerns the gene PTK2B and prostate carcinoma.